This website is intended for journalists outside the US/UK/Canada, who are interested in media information from Boehringer Ingelheim.

Top Stories



    Spiolto® Respimat® approved in first EU countries for COPD


    Myths & Misconceptions - The Anticoagulation Debate

    Events and Initiatives

    ASCO 2015

    14 May 2015

    Education Hub




    Nintedanib* Lume-Lung
    1 Clinical Trial


    Afatinib* Lux-Lung 3 & 6
    Clinical Trials

    Tweets from @Boehringer